Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for Pallidal Deep Brain Stimulation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2018-06-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to compare the efficacy and the safety profile of the newly introduced interleaving stimulation mode to those of the standard double monopolar stimulation mode during pallidal deep brain stimulation of primary generalized or segmental dystonia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia

NCT00331669

Dystonia Movement Disorder

UNKNOWN PHASE2

Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia

NCT00169403

Dystonia

UNKNOWN PHASE3

Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia

NCT02982304

Dystonia Dystonia, Secondary

UNKNOWN PHASE1

Dystonia Image-based Programming of Stimulation: A Prospective, Randomized, Double-blind Crossover Trial

NCT05097001

Dystonia Deep Brain Stimulation

RECRUITING NA

Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia

NCT00142259

Dystonia

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

For the treatment of drug-refractory dystonia, bilateral pallidal deep brain stimulation (GPi-DBS) is proven to be an efficient option. On average, 40-55% improvement on dystonia rating scales (DRS) could be achieved according to the results of multicenter trials lasting for years. However, a considerable portion (10-25%) of the patients experience minimal alleviation despite of good electrode placement. These patients can be regarded as non-responders to GPi-DBS defined as having either limited improvement (\< 25% on DRS) or worsening. Besides adjusting the amplitude, frequency or pulse-width of stimulation, one can change the electrode configuration from the commonly applied single monopolar stimulation mode (one contact on the electrode is negative) to either double monopolar stimulation (two -usually adjacent- negative contacts on the electrode are stimulated with same amplitude and pulse-width values) or bipolar stimulation mode (one contact on the electrode is positive) in case of unsatisfactory outcomes. Although these techniques had been utilized in multicenter trials, non-responsiveness to GPi-DBS did occur. Recently the investigators have reported in the Movement Disorders that the newly introduced interleaving stimulation mode was superior to single or double monopolar stimulation in four patients who had initially (6-12 months after implantation) limited response to GPi DBS.

Aims of the study:

To systematically compare the efficacy and the side-effect profile of double monopolar stimulation mode to those of interleaving stimulation mode in a prospective, randomized, double-blind, and cross-over study.

Methods:

The investigators would enroll 20-25 patients with drug refractory segmental or generalized primary dystonia undergoing bilateral GPi-DBS implantation within a 2-3 year time frame. The inclusion and exclusion criteria would follow those of the study of Kupsch et al.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Dystonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Process 1

* Visit 1: Baseline evaluation (maximum 1 week before operation)
* Visit 2: Testing of electrodes and subsequent initiation of interleaving stimulation mode (4th postoperative week).
* Visit 3 Evaluation and cross-over to double-monopolar stimulation mode (16th postoperative week).
* Visit 4 Final evaluation. (28th postoperative week).

Group Type ACTIVE_COMPARATOR

Interleaving stimulation mode (Medtronic)

Intervention Type DEVICE

Interleaving stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Interleavingr stimulation mode (Medtronic)'

Double monopolar stimulation mode (Medtronic)

Intervention Type DEVICE

Double monopolar stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Double monopolar stimulation mode (Medtronic)'

Process 2

* Visit 1: Baseline evaluation (maximum 1 week before operation)
* Visit 2: Testing of electrodes and subsequent initiation of double-monopolar stimulation mode (4th postoperative week).
* Visit 3 Evaluation and cross-over to interleaving stimulation mode (16th postoperative week).
* Visit 4 Final evaluation. (28th postoperative week).

Group Type ACTIVE_COMPARATOR

Interleaving stimulation mode (Medtronic)

Intervention Type DEVICE

Interleaving stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Interleavingr stimulation mode (Medtronic)'

Double monopolar stimulation mode (Medtronic)

Intervention Type DEVICE

Double monopolar stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Double monopolar stimulation mode (Medtronic)'

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interleaving stimulation mode (Medtronic)

Interleaving stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Interleavingr stimulation mode (Medtronic)'

Intervention Type DEVICE

Double monopolar stimulation mode (Medtronic)

Double monopolar stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Double monopolar stimulation mode (Medtronic)'

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Medtronic Activa RC Interleaving Stimulation Mode Medtronic Activa RC Double Monopolar Stimulation Mode

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ages of 7 and 75 years
* marked disability owing to primary generalized or segmental dystonia, despite optimal pharmacologic treatment
* disease duration of at least 5 years.

Exclusion Criteria

* previous brain surgery;
* cognitive impairment (\< 120 points on the Mattis Dementia Rating Scale)
* moderate-to-severe depression (\> 25 points on the Beck Depression Inventory)
* marked brain atrophy as detected by magnetic resonance imaging
* other medical or psychiatric coexisting disorders that could increase the surgical risk or interfere with completion of the trial

Minimum Eligible Age

7 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No